London & Capital Asset Management Ltd

Position in ABBV — AbbVie Inc.

CIK 1767559 London, X0

Position in ABBV

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,373,954

+$243,876 QoQ

Shares Held

5,460

+5.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#2,259

of 4,153 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

London & Capital Asset Management Ltd holds $7,884,378 across 5 Drug Manufacturers - General names. ABBV ranks #4 (17.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	9,513	$2,416,016
2	LLY	ELI LILLY & Co	1,987	$2,383,267
3	MRK	Merck & Co., Inc.	10,993	$1,412,600
4	ABBV	AbbVie Inc. This page	5,460	$1,373,954
5	GILD	Gilead Sciences, Inc.	2,363	$298,541

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,373,954	5,460	+5.1%	Shares	Sole	2026-08-12
2026-03-31	$1,130,078	5,196	-5.6%	Shares	Sole	2026-05-15
2025-12-31	$1,258,065	5,506	-57.3%	Shares	Sole	2026-02-17
2021-12-31	$1,744,358	12,883	-0.3%	Shares	Other	2022-02-14
2021-09-30	$1,393,464	12,918	+7.8%	Shares	Other	2021-11-15
2021-03-31	$1,296,367	11,979	+13.1%	Shares	Other	2021-05-14
2020-12-31	$1,134,504	10,588	+60.5%	Shares	Other	2021-02-16
2020-06-30	$647,595	6,596	+17.9%	Shares	Other	2020-08-14
2020-03-31	$426,359	5,596	—	Shares	Other	2020-05-15
No filing history on record for this holder in this stock.